Study on Moebius Syndrome and Congenital Facial Weakness Disorders
NCT02055248 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 207
Last updated 2026-04-08
Summary
Background:
\- Moebius syndrome limits the ability to make facial expressions like smile, frown or blink - and move the eyes laterally. It can also cause speech, swallowing or breathing difficulties and affect parts of the body, such as the limbs, jaw, muscles, or the heart. Some individuals with Moebius can have intellectual impairment or behavior problems. Researchers want to study the clinical features of individuals with Moebius or related disorders and explore the genetic and/or environmental causes of these conditions.
Objective:
\- To learn more about the genetics and clinical characteristics of Moebius syndrome and other Congenital Facial Weakness disorders.
Eligibility:
\- People ages 2 to 80 years with congenital facial weakness, isolated or combined with other congenital anomalies, and their family members.
Design:
* Participants with Moebius syndrome or other congenital facial weakness disorder will be evaluated at the NIH Clinical Research Center over 3 to 5 days and undergo the following procedures:
* Medical and family history and physical examination, including body measurements and vital signs.
* Blood or saliva will be collected for genetic tests and to evaluate liver, kidney, heart and hormonal
functions.
* Eye examination, including having a video taken of their eyes moving.
* Hearing evaluation.
* Speech and language assessment, including swallowing studies.
* Dental exam.
* Detailed neurological evaluation, including electromyogram/nerve conduction and blink reflex study.
* Rehabilitation medicine evaluation, including muscle and tongue strength testing and assessment of balance.
* Neurocognitive and behavioral testing and questionnaires to assess quality of life and copying mechanisms.
* Imaging studies of their head, by magnetic resonance and diffusion tensor imaging -MRI/DTI. Participants
will lie on a table that slides into a metal cylinder that takes images of internal body structures using
magnets. Child participants may be sedated.
* Some adults may have additional X-rays of their head or limbs, if there are abnormal findings.
* Medical photographs of the face and affected body parts may be taken.
* Other specialized tests or consultations, as indicated.
* Participants can choose to have a skin biopsy taken.
* A follow-up visit will be offered to participants for review of genetic test findings and possibly additional clinical tests, as indicated.
Family members of the patients will have a medical and family history and physical examination. Blood or saliva will be obtained for genetic studies.
Conditions
- Brain Disorders
- Birth Defects
- Craniofacial Differences
Sponsors & Collaborators
-
National Eye Institute (NEI)
collaborator NIH -
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
collaborator NIH -
Icahn School of Medicine at Mount Sinai
collaborator OTHER - collaborator OTHER
-
National Human Genome Research Institute (NHGRI)
lead NIH
Principal Investigators
-
Eirini Manoli, M.D. · National Human Genome Research Institute (NHGRI)
Eligibility
- Min Age
- 2 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-05-20
- Primary Completion
- 2020-04-29
- Completion
- 2020-04-29
Countries
- United States
Study Locations
More Related Trials
-
A Prospective Natural History Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)
NCT03227042 ·Status: ACTIVE_NOT_RECRUITING
-
Psychological Concomitants of Morquio A Syndrome - Longitudinal Effects of Enzyme Replacement Therapy (The MAPLE Study)
NCT02208661 ·Status: COMPLETED
-
Psychological Concomitants of Morquio Syndrome (The MAP Study)
NCT01752296 ·Status: COMPLETED
-
Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C
NCT00344331 ·Status: RECRUITING
-
The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome
NCT00768820 ·Status: RECRUITING ·Phase: PHASE4
-
Saccadic Eye Movements in Patients With Niemann-Pick Type C Disease
NCT00316498 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome
NCT04977986 ·Status: COMPLETED ·Phase: PHASE3
-
Core Outcome Set for Head, Neck and Respiratory Disease in Mucopolysaccharidosis II
NCT06022380 ·Status: COMPLETED
-
The Effect of Enzyme Replacement Therapy in Mucopolysaccharidosis
NCT05006222 ·Status: COMPLETED ·Phase: NA
-
Natural History Studies of Mucopolysaccharidosis III
NCT02037880 ·Status: COMPLETED
-
A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN, or LRP4
NCT06078553 ·Status: RECRUITING
-
Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy
NCT03692312 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Brain and Neuropsychological Functioning in Adults With Sapropterin Dihydrochloride Treated Phenylketonuria
NCT02297347 ·Status: COMPLETED
-
STXBP1 and SYNGAP1 Related Disorders Natural History Study
NCT06555965 ·Status: RECRUITING
-
Respiratory Cathepsins, Proteases Inhibitors and Glycosaminoglycans (GAG) in Mucopolysaccharidosis
NCT04112602 ·Status: COMPLETED
-
Miglustat in Niemann-Pick Type C Disease
NCT00517153 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD
NCT02451696 ·Status: COMPLETED ·Phase: PHASE2
-
New Imaging Technology to Assess Effect of Enzyme Replacment Therapy on Eye Disease Progession in Mucopolysacchardiosis
NCT02583152 ·Status: UNKNOWN
-
A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas
NCT00634270 ·Status: COMPLETED ·Phase: PHASE2
-
A 2-Part Study to Assess Efficacy, Safety and Tolerability of BMB-101 for the Treatment of Patients With Prader-Willi Syndrome.
NCT07266324 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Natural History Study of Biomarkers and Clinical Outcomes in Mucopolysaccharidosis Type IIIA (MPS IIIA; Sanfilippo Syndrome)
NCT05523206 ·Status: COMPLETED
-
Evaluate Safety and Biological Activity of ATYR1940 in Participants With Early Onset Facioscapulohumeral Muscular Dystrophy
NCT02603562 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Improve the Awareness of Mucopolysaccharidosis Type II in Brazil
NCT05155488 ·Status: COMPLETED
-
FSHD Molecular Characterization
NCT06096441 ·Status: TERMINATED
-
Lysosomal Storage Disease: Health, Development, and Functional Outcome Surveillance in Preschool Children
NCT01938014 ·Status: COMPLETED